A detailed history of Strategic Advocates LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Strategic Advocates LLC holds 14 shares of JNJ stock, worth $2,794. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Holding current value
$2,794
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 26, 2025

BUY
$155.17 - $185.42 $2,172 - $2,595
14 New
14 $2.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Strategic Advocates LLC Portfolio

Follow Strategic Advocates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Advocates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Advocates LLC with notifications on news.